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Background: Staphylococcus aureus is a major human pathogen. Panton-Valentine
leukocidin (PVL) is a virulence factor produced by some strains that causes leukocyte
lysis and tissue necrosis. PVL-associated S. aureus (PVL-SA) predominantly causes
skin and soft-tissue infections (SSTIs) but can also cause invasive infections such as
necrotizing pneumonia. It is carried by both community-associatedmethicillin susceptible
S. aureus (CA-MSSA) and methicillin resistant S. aureus (CA-MRSA). This study aims to
determine the prevalence of PVL-SA among patients seen at an urban Gambian hospital
and associated antibiotic resistance.
Methods: Archived clinical S. aureus (70 invasive bacteraemia and 223 non-invasive
SSTIs) from 293 patients were retrieved as well as relevant data from clinical records
where available. Antibiotic susceptibility was assessed using disc diffusion according to
Clinical Laboratory Standards Institute (CLSI) guidelines. Genomic DNA was extracted
and the presence of lukF and lukS PVL genes was detected by conventional
gel-based PCR.
Result: PVL-SA strains accounted for 61.4% (180/293) of S. aureus isolates. PVL
prevalence was high in both Gambian bacteraemia and SSTIs S. aureus strains.
Antimicrobial resistance was low and included chloramphenicol (4.8%), cefoxitin
(2.4%), ciprofloxacin (3.8%), erythromycin (8.9%), gentamicin (5.5%) penicillin (92.5%),
tetracycline (41.0%), and sulfamethoxazole-trimethoprim (24.2%). There was no
association of PVL with antimicrobial resistance.
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Conclusion: PVL expression is high among clinical S. aureus strains among Gambian
patients. Reporting of PVL-SA clinical infections is necessary to enable the monitoring of
the clinical impact of these strains in the population and guide prevention of the spread
of virulent PVL-positive CA-MRSA strains.
SUMMARY
Staphylococcus aureus (S. aureus) is a major human pathogen with several virulence
factors. We performed a retrospective analysis to investigate the prevalence of one such
virulence factor (PVL) amongst clinical S. aureus samples. We found a high prevalence
in our setting but antimicrobial resistance including methicillin resistance was low.
Keywords: Panton-Valentine leukocidin, Staphylococcus aureus, community-acquired, antimicrobial resistance,
The Gambia
INTRODUCTION
Staphylococcus aureus (S. aureus) is a major human pathogen
causing infections ranging from mild skin and soft-tissue
infections to life-threatening sepsis, and implicated in both
community acquired (CA) and healthcare-associated (HA)
infections with significant morbidity and mortality (Boyle-
Vavra and Daum, 2007; Breurec et al., 2011a; Ozekinci et al.,
2014). A major predisposing factor for infection is surface
colonization; S. aureus colonization of the skin and mucus
membranes is estimated in 30% of healthy individuals while a
further 30% are transient carriers (Chambers and Deleo, 2009;
Shallcross et al., 2013). The remarkable capacity to acquire
methicillin resistance first in hospitals and more recently in
community strains adds to the success of S. aureus as a
pathogen due to widespread use of β-lactams in the treatment
of infection (Cosgrove et al., 2003).
The pathogenesis of S. aureus is mediated by several cell
surface and secreted virulence factors. One such virulence
factor, Panton-Valentine leukocidin (PVL) is a two-component
toxin, that induces pore formation in the leukocyte cell
membrane complement receptors (Rasigade et al., 2010).
These two genes (LukS-PV and LukF-PV) encode two
proteins which are co-transcribed and secreted separately
to form a complete heptavalent leukocidin (Boyle-Vavra and
Daum, 2007; Rasigade et al., 2010). Although produced
by <5% of S. aureus strains, PVL is detected in large
percentages of isolates that cause necrotic skin lesions and
severe necrotizing pneumonia (Lina et al., 1999; Labandeira-
Rey et al., 2007; Shallcross et al., 2013). PVL-associated S.
aureus (PVL-SA) infection is commonly associated with
community-acquired methicillin resistant S. aureus (CA-
MRSA) (Asiimwe et al., 2017), but outbreaks due to PVL-pos
methicillin-susceptible S. aureus (MSSA) strains have been
reported in close community settings (Boubaker et al., 2004;
Rasigade et al., 2010). However, the potential risk of spread to
hospital is considered a significant public health concern, as
establishment of a PVL positive clonal lineage of HA-MRSA
could rapidly lead to dramatically worse outcomes for HA-
MRSA patients (Witte, 2009; Breurec et al., 2011b). There are
clonal lineages from which HA-MRSA and CA-MRSA have
been reported (Boyle-Vavra and Daum, 2007; Witte, 2009;
Breurec et al., 2011b).
Invasive S. aureus infections throughout Europe, America
and parts of Africa are often caused by strains lacking the
PVL gene (Shallcross et al., 2013), however, some studies
have described the epidemiological relevance of PVL-positive
MSSA as a reservoir for CA-MRSA and a marker of
severe infection (Witte, 2009; Rasigade et al., 2010). The
higher pathogenic potential and recurrence of CA-MRSA has
been attributed to the ability of these organisms to express
PVL (Breurec et al., 2011b). However, the role of PVL
alone on severity of disease is controversial with studies
suggesting additional role of hemolysin β contributing to
virulence thus the need for more robust study on hemolysins
(Lebughe et al., 2017). Data across West Africa (Senegal,
Cameroon, and Ghana) indicate a high prevalence of PVL-
positive MSSA in infection, as opposed to North, East and
Southern Africa (Breurec et al., 2011a; Egyir et al., 2014;
Dekker et al., 2016; Asiimwe et al., 2017) and in the UK
(Shallcross et al., 2010).
No data on PVL prevalence has been reported in The
Gambia and it is paramount to determine the prevalence
of a potential virulence gene cluster in the strains present.
This study aims to determine the PVL prevalence and its
association with antibiotic resistance in S. aureus isolated from
clinical strains between 2005 and 2015 in an urban hospital of
The Gambia.
METHODS
Setting and Population
The study was conducted in the Clinical Services Department
(CSD) of the Medical Research Council Unit The Gambia
(MRCG) at the LSHTM, Fajara which is located in the urban
western region of The Gambia and serves the population
mainly from this region. The population of the Gambia is 2.1
million (The Gambia Bureau Statistics, 2014) and the hospital
has a 42-bed in-patient unit and an outpatients’ department
seeing more than 50,000 patients annually. It is the only health
facility were routine microbiological investigations are carried
out for patients in this region. Pathogens of clinical significance
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were stored in −70◦C for potential future research of public
health significance.
Study Design
This was a cross sectional study based on data compiled from
records and samples for patients seen at The MRCG clinic
during the period January 2005—December 2015 to determine
the presence of PVL in Gambian clinical S. aureus. All S.
aureus positive blood cultures from patients with suspected
sepsis during the study period were included. SSTI samples
from skin related infections such as pus, wounds etc. collected
from clinically symptomatic cases within 2 weeks as the invasive
samples for culture and antimicrobial testing were included in
this study. Isolates were retrieved for patients who had S. aureus
isolated within 72 h of admission and on day of visit for those
from outpatients. Duplicate isolates from the same patient were
excluded. Invasive isolates from other sites other than blood
culture were also excluded.
Clinical Data
Clinical records were retrieved for invasive cases and reviewed,
where available, to ascertain length of hospital stay, severity of
disease and mortality.
Microbiological Procedures
Two hundred and ninety-three (293) S. aureus isolates collected
from 293 patients were retrieved from storage at−70◦C. Invasive
isolates were all from blood (70/293; 24%) and 223 were from
non-invasive skin and soft tissue. Isolates were sub cultured on
blood agar and incubated overnight at 37◦C.
Isolates were identified using a combination of enzymatic and
fermentation tests, including catalase, tube coagulase, DNase, and
mannitol fermentation.
Antimicrobial susceptibility was done by disc diffusion
according to the Clinical Laboratory Standard Institute (CLSI)
guidelines (CLSI., 2015) using the following antibiotics: cefoxitin
(Fox), chloramphenicol (C), ciprofloxacin (Cip), erythromycin
(E), gentamicin (Cn), penicillin (P), sulfamethoxazole-
trimethoprim (Sxt), and tetracycline (Te). The cefoxitin
disc was used as a surrogate for all penicillinase-stable penicillins
and resistance was used to infer mecA-mediated methicillin
resistance. Where cefoxitin was resistant by disc diffusion,
an oxacillin E-test (bioMérieux, Marcy l’Etoile, France)
was performed, with an oxacillin MIC ≥4 ug/mL used to
define methicillin resistance (CLSI., 2015). The antimicrobial
susceptibility testing was carried out using the coagulase positive
methicillin susceptible S. aureus ATCC 25923 and coagulase
negative Staphylococcus epidermidis ATCC 12228, respectively
for quality control.
Molecular Typing by Gel Based PCR
Genomic DNA was extracted using QIAamp DNA Mini Kit
(QIAGEN, Netherlands). Isolated colonies were suspended
in 1X TE buffer to 1.0 McFarland Standard turbidity and
suspended cells were then lysed in lysostaphin (Sigma-L7386) at
a concentration of 200µg/ml and DNA extraction performed as
per the Qiagen protocol. N65 (PVL and γ-hemolysin deficient)
(Supersac et al., 1993) and ATCC 49775 (PVL and γ-hemolysin)
(Supersac et al., 1998) were used as negative and positive
controls, respectively.
The conventional gel-based PCR reaction mix was performed
in a 25 µl reaction volume, which included 12.5 µl of 2X
Taq master mix (Qiagen, Netherlands), and 2 µl of 10µM
concentration forward and reverse primers. At least 50 ng
of extracted genomic DNA was required for each reaction.
Primers used for detecting presence of lukF-PV and lukS-PV
PVL genes were designed using GenBank sequences (accession
numbers AB006796 and L01055). Primers to amplify 16S rDNA
have previously been established (De Buyser et al., 1989).
The following PCR conditions were used for PVL PCRs: an
initial denaturation of 94◦C for 3min followed by 35 cycles
of denaturation at 94◦C for 1min, annealing temperatures of
60◦C for lukSPV and 55◦C for lukFPV, and an extension of
72◦C for 1min. Final extension was at 72◦C for 10min. Post
PCR gel electrophoresis was performed to identify the presence
or absence of the above-mentioned genes. The gel percentage
used was as per the fragment size of the gene concerned. Ten
percentage of the samples were randomly selected and repeated
by a different individual for reproducibility and they were found
to be reproducible.
Statistical Analysis
Data were analyzed using STATA version 12.1. Sample
characteristics and the prevalence of S. aureus by sample
type were generated using summary tables. A chi-squared
test was used to determine the association between PVL
status and sample type. Logistic regression models were
fitted to determine the association between PVL status and
antimicrobial resistance.
Ethical Review and Approval
The study received ethical approval from the Joint MRCG
@LSHTM/Gambia Government Ethics Committee. Clinical
samples were collected for standard clinical management and the
results were anonymized for analytical purpose.
RESULTS
The median age of individuals in the study was 48 months (IQR
12, 252) (Table 1). The overall prevalence of PVL genes was
180/293; 61.4% (95% CI: 55.6%, 67.0%), with some evidence (p
= 0.024) of higher prevalence seen in invasive samples 51/70;
72.9% than non-invasive samples 129/223; 57.9% (Table 1). PVL
prevalence was consistently high across all the years exceeding
20% (Figure 1).
Antimicrobial resistance (AMR) to various antimicrobials
was analyzed (Figure 2). Resistance to penicillin (penicillinase-
labile) (271/293; 92.5%) was high but low for penicillinase-
stable penicillins such as methicillin (7/293; 2.4%). Association
between AMR and with PVL status was also analyzed (Figure 3).
Although methicillin resistant S. aureus (MRSA) rates were
low, no difference was found in the rate of PVL prevalence in
4/7 (57.1%) of MRSA cases compared with the MSSA 176/286
(61.5%). The range of oxacillin MICs in the seven MRSA isolates
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TABLE 1 | Sample characteristics.
Variable Category n = 293 PVL status
Positive (%)
Age group <2 months 33 25 (75.8)
2–23 months 65 44 (67.7%)
24–59 months 36 17 (47.2%)
5–14 years 53 35 (66.0%)
≥15 years 106 59 (55.7%)
Sex* Female 150 92 (61.3%)
Male 140 87 (62.1%)
Sample type Skin and soft tissues 223 129 (57.9%)
Bacteraemia 70 56 (71.8%)
Year 2005 29 7 (24.1%)
2006 20 10 (50.0%)
2007 10 8 (80.0%)
2008 27 19 (70.4%)
2009 22 16 (72.7%)
2010 5 3 (60.0%)
2011 16 14 (87.5%)
2012 22 18 (81.8%)
2013 22 19 (86.4%)
2014 54 36 (66.7%)
2015 66 30 (45.5%)
*Some missing data. Overall PVL prevalence and 95% CI = 180/293 = 61.4%
(55.6%, 67.0%).
FIGURE 1 | Bar plot showing proportion of PVL positive samples by year.
was universally high, between ≥9 and ≥23µg/mL, denoting
significant resistance to penicillinase-stable penicillins. There was
no evidence of association between antimicrobial resistance and
PVL status. Although clinical data was only available for a subset
of cases of bacteraemia (29/70), length of hospital stay, mortality
or gender were not associated with PVL status (p= 0.4).
DISCUSSION
This study raises awareness of the important virulent gene cluster
present in S. aureus causing disease in our setting. This study
FIGURE 2 | Bar graph showing resistant samples by drug. Pen, Penicillin; Tri,
Trimethoprim-sulphamethoxazole; Gen, Gentamicin; Tet, Tetracycline; Cip,
Ciprofloxacillin; Cef, Cefoxitin; Ery, Erythromycin; Chl, Chloramphenicol.
confirms high PVL prevalence in S. aureus causing disease
and contributes to current knowledge in prevalence of PVL in
The Gambia where S. aureus is currently the most prevalent
pathogen causing bacteraemia (Darboe et al., 2019) (accepted for
publication CID).
The prevalence of PVL (72.9%) in invasive disease was
unusually high but similar to that found in Ghana (75%)
(Dekker et al., 2016), and greater than reported in the
neighboring country of Senegal (47%), elsewhere in Africa
and across the globe (Breurec et al., 2011a; Shallcross et al.,
2013). Prevalence in SSTI however was similar to other West
African countries including Senegal (Breurec et al., 2011a).The
study also confirms that PVL prevalence was high across all
age groups.
Antibiotic susceptibility was similar to what was described
for S. aureus causing infection in other parts Africa where
multidrug resistance continues to be high for penicillin,
sulfamethoxazole-trimethoprim and tetracycline (Schaumburg
et al., 2014; Dekker et al., 2016), reflecting the frequent use
of these drugs in the community. MRSA continues to occur
at low prevalence (2.6% of infections), similar to what was
described in Ghana and neighboring Senegal (Dekker et al.,
2016) as opposed to what is described for other parts of Africa
(Breurec et al., 2011a). Although resistance to sulfamethoxazole-
trimethoprim was high, no association was found between PVL
expression in contrast to what was found in Saudi Arabia (Bazzi
et al., 2015), Nigeria (Ayepola et al., 2018), and in Gabon
(Kraef et al., 2015).
In this study, we did not find evidence for an association
between PVL status and length of hospital stay in patients
admitted for bacteraemia supporting the evidence that PVL-
positive strains does not predict poor outcome in these patients
(Shallcross et al., 2013). This may highlight the fact that PVL
status has no impact on pathogenicity in invasive disease as
the presence of the gene does not infer expression (Ayepola
et al., 2018). We did not compare clinical outcome and PVL
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FIGURE 3 | Association between antimicrobial resistance and PVL status. Results from crude and adjusted binary logistic regression models with resistance to each
of the antibiotics as the outcome and PVL status as the predictor. ORs and 95% CIs on the log scale for PVL status are presented based on models: — Unadjusted
for any covariate; — Adjusted for continuous age, sex, year of sample collection; — Adjusted for categorical age, sex, year of sample collection; — Adjusted for
categorical age, sex, year of sample collection, sample type; — Adjusted for categorical age, sex, year of sample collection (Categorical in two periods), sample type.
Pen, Penicillin; Tri, Trimethoprim-sulphamethoxazole; Gen, Gentamicin; Tet, Tetracycline; Cip, Ciprofloxacillin; Cef, Cefoxitin; Ery, Erythromycin; Chl, Chloramphenicol.
status in SSTIs where strong association is suggested in many
studies (Shallcross et al., 2010, 2013; Ozekinci et al., 2014). Other
studies have linked younger age, hospitalization and severity
of disease as risk factors for PVL (Muttaiyah et al., 2010). In
a study in Taiwan, PVL positive MSSA infection was linked
to longer duration of fever (Chiu et al., 2012). There is also
strong evidence that PVL is associated with disease and less with
colonization; with certain lineages and sequence types (ST) such
as ST152, ST121, and ST5 more likely to harbor it (Breurec
et al., 2011a; Shallcross et al., 2013; Egyir et al., 2014; Ayepola
et al., 2015). The findings of various studies are summarized
in Appendix 1.
There are several limitations of this study. The first and
most important being the inclusion of only one hospital and
sampling based on availability of isolate. This may not be
representative of the entire country. Another limitation is that,
being a retrospective study, it was not possible to inform the
attending physicians of the results to impact on care. Although
patients were mostly directly from the community, occasional
admissions within 3 days were all assumed to be community
acquired and risk factors of disease were not ascertained.
Length of hospital stay was not analyzed for many patients
due to lack of clinical records. Other clinical outcomes such
as prognosis and mortality were not assessed due to limited
data. In addition, SSTIs were not categorized into the various
sample types and clinical outcome was not assessed. Contact
tracing among family members and sequencing the strains for
genetic relatedness would also have been useful. PVL phenotypic
expression was not confirmed to compare rate detected against
that expressed. Future research should consider these and other
typing for lineages based on sequence types and staphylococcal
protein A (spa) to provide more information into S. aureus
lineages circulating especially for strains causing bacteraemia
and meningitis.
Notwithstanding, this paper has filled a knowledge gap
for this pathogen. Our sample size was reasonably large and
longitudinal as well as being the first published literature
to determine the presence of such an important virulence
gene in a setting that has low prevalence of MRSA. We
have demonstrated that contrary to the rarity of PVL in
invasive disease reported (Shallcross et al., 2013), we have a
high prevalence, concordant with rates found in neighboring
Senegal and Ghana (Breurec et al., 2011a; Dekker et al., 2016).
The CA-MRSA in the Senegal/Gambia region of West Africa
may be a potential emerging public health concern as they
may serve as reservoir for the potential spread of virulent
strains into healthcare. Hence this requires close monitoring
to inform treatment options and the development of strategies
to control the spread of these difficult to treat infections in
the region.
In conclusion, PVL prevalence was high in both Gambian
invasive and SSTIs S. aureus strains and no association was found
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with antimicrobial resistance. These findings warrant further
investigation into the diversity of S. aureus lineages as this could
be an important finding to assess the likely reservoir for PVL-
positive CA-MRSA in our setting.
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